, a bio/informatics shared resource is still "open for business" - Visit the CDS website

PDF

Type 1 and Type 2 Diabetes Drug Study

TBD

Category
Page
Record History
Added on September 25, 2017 at 10:18 AM by Kimber, Jessica
Modified on September 25, 2017 at 10:18 AM by Kimber, Jessica
Shared with (contributions)
DRTC: Clinical Trials Master

Type 1 and Type 2 Diabetes Drug Study

The purpose of this study is to compare commonly used diabetes medications in relation to gylcemia-lowering effectiveness in diabetes patients.

 

To qualify to participate:

  • Be 30 years of age or older

  • Men or women diagnosed with diabetes at age ≥ 30 years (≥ 20 for American Indians)

  • Duration of diagnosed diabetes < 10 years

  • Willingness to administer daily subcutaneous injections, take a second diabetes drug after randomization, potentially initiate insulin and intensify insulin therapy if study metabolic goals are not met, perform self-monitoring of blood glucose

  • Fluent in either English or Spanish

  • A negative pregnancy test for all females of childbearing potential (i.e. pre-menopausal, and not surgically sterile)

 

How to Participate

To participate, contact Stephanie Martin at (615) 936-1075 or e-mail at stephanie.michon@vanderbilt.edu.